Quoc Le Nguyen is of 89bio, Inc.. Currently has a direct ownership of 222,149 shares of ETNB, which is worth approximately $1.69 Million. The most recent transaction as insider was on Feb 17, 2024, when has been sold 1,046 shares (Common Stock) at a price of $9.74 per share, resulting in proceeds of $10,188. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 222K
0% 3M change
30.35% 12M change
Total Value Held $1.69 Million

Quoc Le-Nguyen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 17 2024
SELL
Payment of exercise price or tax liability
$10,188 $9.74 p/Share
1,046 Reduced 0.47%
222,149 Common Stock
Feb 09 2024
SELL
Payment of exercise price or tax liability
$30,149 $8.45 p/Share
3,568 Reduced 1.57%
223,195 Common Stock
Feb 05 2024
SELL
Payment of exercise price or tax liability
$11,662 $9.8 p/Share
1,190 Reduced 0.52%
226,763 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
48,750 Added 17.62%
227,953 Common Stock
Jan 05 2024
SELL
Payment of exercise price or tax liability
$111,506 $11.53 p/Share
9,671 Reduced 5.12%
179,203 Common Stock
Jan 05 2024
BUY
Grant, award, or other acquisition
-
25,000 Added 11.69%
188,874 Common Stock
Sep 09 2023
SELL
Payment of exercise price or tax liability
$82,352 $16.61 p/Share
4,958 Reduced 2.94%
163,874 Common Stock
Aug 01 2023
SELL
Payment of exercise price or tax liability
$24,740 $15.55 p/Share
1,591 Reduced 0.93%
168,832 Common Stock
Jun 30 2023
SELL
Payment of exercise price or tax liability
$54,613 $18.95 p/Share
2,882 Reduced 1.66%
170,423 Common Stock
Jun 30 2023
BUY
Grant, award, or other acquisition
-
8,334 Added 4.59%
173,305 Common Stock
May 09 2023
SELL
Open market or private sale
$247,799 $18.11 p/Share
13,683 Reduced 7.66%
164,971 Common Stock
May 09 2023
BUY
Exercise of conversion of derivative security
$247,465 $3.11 p/Share
79,571 Added 30.81%
178,654 Common Stock
Mar 31 2023
SELL
Payment of exercise price or tax liability
$63,646 $15.23 p/Share
4,179 Reduced 4.05%
99,083 Common Stock
Mar 31 2023
BUY
Grant, award, or other acquisition
-
12,083 Added 10.74%
100,380 Common Stock
Feb 17 2023
SELL
Payment of exercise price or tax liability
$29,895 $13.97 p/Share
2,140 Reduced 2.29%
91,179 Common Stock
Feb 09 2023
BUY
Grant, award, or other acquisition
-
30,000 Added 24.33%
93,319 Common Stock
Feb 05 2023
SELL
Payment of exercise price or tax liability
$18,403 $13.24 p/Share
1,390 Reduced 2.15%
63,319 Common Stock
Feb 01 2023
SELL
Payment of exercise price or tax liability
$8,374 $12.05 p/Share
695 Reduced 1.06%
64,709 Common Stock
Sep 30 2022
SELL
Payment of exercise price or tax liability
$7,510 $5.79 p/Share
1,297 Reduced 1.94%
65,404 Common Stock
Sep 30 2022
BUY
Grant, award, or other acquisition
-
3,750 Added 5.32%
66,701 Common Stock
Sep 28 2022
SELL
Payment of exercise price or tax liability
$16,600 $5.76 p/Share
2,882 Reduced 4.38%
62,951 Common Stock
Sep 28 2022
BUY
Grant, award, or other acquisition
-
8,333 Added 11.24%
65,833 Common Stock
Sep 09 2022
BUY
Grant, award, or other acquisition
-
25,000 Added 30.3%
57,500 Common Stock
Feb 17 2022
BUY
Grant, award, or other acquisition
-
22,500 Added 40.91%
32,500 Common Stock
Feb 05 2022
SELL
Payment of exercise price or tax liability
$7,128 $5.23 p/Share
1,363 Reduced 4.19%
31,137 Common Stock
QL

Quoc Le Nguyen

San Francisco, CA

Track Institutional and Insider Activities on ETNB

Follow 89bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETNB shares.

Notify only if

Insider Trading

Get notified when an 89bio, Inc. insider buys or sells ETNB shares.

Notify only if

News

Receive news related to 89bio, Inc.

Track Activities on ETNB